Y Intercept Hong Kong Ltd bought a new stake in eHealth, Inc. (NASDAQ:EHTH - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 105,655 shares of the financial services provider's stock, valued at approximately $706,000. Y Intercept Hong Kong Ltd owned about 0.35% of eHealth at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. Millennium Management LLC boosted its stake in shares of eHealth by 83.3% in the 4th quarter. Millennium Management LLC now owns 404,912 shares of the financial services provider's stock valued at $3,806,000 after purchasing an additional 183,956 shares during the last quarter. 683 Capital Management LLC bought a new position in shares of eHealth in the 4th quarter valued at about $470,000. Raymond James Financial Inc. bought a new position in shares of eHealth in the 4th quarter valued at about $1,193,000. Quinn Opportunity Partners LLC boosted its stake in shares of eHealth by 154.8% in the 4th quarter. Quinn Opportunity Partners LLC now owns 79,000 shares of the financial services provider's stock valued at $743,000 after purchasing an additional 48,000 shares during the last quarter. Finally, Point72 Asset Management L.P. bought a new position in shares of eHealth in the 4th quarter valued at about $1,383,000. Institutional investors own 79.54% of the company's stock.
eHealth Price Performance
eHealth stock opened at $3.84 on Friday. eHealth, Inc. has a fifty-two week low of $3.58 and a fifty-two week high of $11.36. The company's 50 day simple moving average is $4.16 and its 200 day simple moving average is $6.54. The firm has a market capitalization of $116.47 million, a price-to-earnings ratio of -3.92 and a beta of 0.97.
eHealth (NASDAQ:EHTH - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The financial services provider reported ($0.33) earnings per share for the quarter, beating analysts' consensus estimates of ($0.41) by $0.08. eHealth had a net margin of 4.14% and a return on equity of 2.16%. The firm had revenue of $113.12 million for the quarter, compared to analyst estimates of $99.46 million. As a group, analysts predict that eHealth, Inc. will post -2.17 EPS for the current fiscal year.
Analyst Ratings Changes
EHTH has been the topic of several recent research reports. Wall Street Zen lowered shares of eHealth from a "buy" rating to a "hold" rating in a research note on Sunday, May 11th. Royal Bank Of Canada reissued a "sector perform" rating and set a $11.00 price objective on shares of eHealth in a research note on Monday, May 19th. Finally, UBS Group reduced their price objective on shares of eHealth from $9.50 to $7.00 and set a "neutral" rating on the stock in a research note on Thursday, May 8th. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat.com, eHealth currently has an average rating of "Hold" and a consensus target price of $6.75.
Get Our Latest Research Report on eHealth
eHealth Profile
(
Free Report)
eHealth, Inc operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. The company operates in two segments, Medicare; and Employer and Individual. The Medicare segment offers sale of Medicare-related health insurance plans, which includes Medicare advantage, Medicare Supplement, and Medicare Part D prescription drug plans to Medicare-eligible customers including but not limited to, dental, and vision insurance, as well as advertising program for marketing and other services.
Featured Articles
Want to see what other hedge funds are holding EHTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for eHealth, Inc. (NASDAQ:EHTH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider eHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and eHealth wasn't on the list.
While eHealth currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.